1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

P.a.w. Capital Corp Buys BlackRock TCP Capital Corp, Pieris Pharmaceuticals Inc, The Rubicon Project Inc, Sells BlackRock TCP Capital Corp, Akebia Therapeutics Inc, Galapagos NV

Greenwich, CT, based Investment company P.a.w. Capital Corp buys BlackRock TCP Capital Corp, Pieris Pharmaceuticals Inc, The Rubicon Project Inc, Exicure Inc, Krystal Biotech Inc, Cue Biopharma Inc, CytoSorbents Corp, CV Sciences Inc, USA Technologies Inc, sells BlackRock TCP Capital Corp, Akebia Therapeutics Inc, Galapagos NV, Semler Scientific Inc, Eiger BioPharmaceuticals Inc during the 3-months ended 2018-09-30, according to the most recent filings of the investment company, P.a.w. Capital Corp. As of 2018-09-30, P.a.w. Capital Corp owns 66 stocks with a total value of $94 million. These are the details of the buys and sells.

For the details of P.A.W. CAPITAL CORP's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=P.A.W.+CAPITAL+CORP

These are the top 5 holdings of P.A.W. CAPITAL CORP
  1. Attunity Ltd (ATTU) - 240,000 shares, 4.81% of the total portfolio. Shares reduced by 20%
  2. Allot Communications Ltd (ALLT) - 700,000 shares, 4.59% of the total portfolio. Shares reduced by 2.78%
  3. FireEye Inc (FEYE) - 250,000 shares, 4.51% of the total portfolio.
  4. R1 RCM Inc (RCM) - 400,000 shares, 4.31% of the total portfolio.
  5. Chegg Inc (CHGG) - 135,000 shares, 4.07% of the total portfolio. Shares reduced by 10%
New Purchase: BlackRock TCP Capital Corp (8TC)

P.a.w. Capital Corp initiated holding in BlackRock TCP Capital Corp. The purchase prices were between $11.92 and $13.1, with an estimated average price of $12.5. The stock is now traded at around $12.12. The impact to a portfolio due to this purchase was 1.74%. The holding were 115,000 shares as of 2018-09-30.

New Purchase: Pieris Pharmaceuticals Inc (PIRS)

P.a.w. Capital Corp initiated holding in Pieris Pharmaceuticals Inc. The purchase prices were between $4.99 and $6.42, with an estimated average price of $5.43. The stock is now traded at around $4.78. The impact to a portfolio due to this purchase was 1.49%. The holding were 250,000 shares as of 2018-09-30.

New Purchase: The Rubicon Project Inc (RUBI)

P.a.w. Capital Corp initiated holding in The Rubicon Project Inc. The purchase prices were between $2.78 and $4.06, with an estimated average price of $3.53. The stock is now traded at around $3.51. The impact to a portfolio due to this purchase was 1.15%. The holding were 300,000 shares as of 2018-09-30.

New Purchase: Exicure Inc (XCUR)

P.a.w. Capital Corp initiated holding in Exicure Inc. The purchase prices were between $4.09 and $6.5, with an estimated average price of $5.19. The stock is now traded at around $3.97. The impact to a portfolio due to this purchase was 0.87%. The holding were 200,000 shares as of 2018-09-30.

New Purchase: Krystal Biotech Inc (KRYS)

P.a.w. Capital Corp initiated holding in Krystal Biotech Inc. The purchase prices were between $14.43 and $21, with an estimated average price of $16.78. The stock is now traded at around $21.21. The impact to a portfolio due to this purchase was 0.56%. The holding were 30,000 shares as of 2018-09-30.

New Purchase: CytoSorbents Corp (CTSO)

P.a.w. Capital Corp initiated holding in CytoSorbents Corp. The purchase prices were between $10.95 and $14.8, with an estimated average price of $12.55. The stock is now traded at around $10.33. The impact to a portfolio due to this purchase was 0.14%. The holding were 10,000 shares as of 2018-09-30.

Added: Cue Biopharma Inc (CUE)

P.a.w. Capital Corp added to a holding in Cue Biopharma Inc by 166.67%. The purchase prices were between $7.91 and $11.89, with an estimated average price of $9.66. The stock is now traded at around $6.72. The impact to a portfolio due to this purchase was 0.48%. The holding were 80,000 shares as of 2018-09-30.

Sold Out: BlackRock TCP Capital Corp (TCPC)

P.a.w. Capital Corp sold out a holding in BlackRock TCP Capital Corp. The sale prices were between $14.2 and $14.93, with an estimated average price of $14.63.

Sold Out: Akebia Therapeutics Inc (AKBA)

P.a.w. Capital Corp sold out a holding in Akebia Therapeutics Inc. The sale prices were between $7.44 and $10.65, with an estimated average price of $8.95.

Sold Out: Galapagos NV (GLPG)

P.a.w. Capital Corp sold out a holding in Galapagos NV. The sale prices were between $90.63 and $120.22, with an estimated average price of $105.38.

Sold Out: Macrogenics Inc (MGNX)

P.a.w. Capital Corp sold out a holding in Macrogenics Inc. The sale prices were between $19.26 and $23.46, with an estimated average price of $21.32.

Sold Out: Dick's Sporting Goods Inc (DKS)

P.a.w. Capital Corp sold out a holding in Dick's Sporting Goods Inc. The sale prices were between $32.97 and $39.43, with an estimated average price of $35.84.



Here is the complete portfolio of P.A.W. CAPITAL CORP. Also check out:

1. P.A.W. CAPITAL CORP's Undervalued Stocks
2. P.A.W. CAPITAL CORP's Top Growth Companies, and
3. P.A.W. CAPITAL CORP's High Yield stocks
4. Stocks that P.A.W. CAPITAL CORP keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK